Digital solutions
for the pharmaceutical industry.
Sinorfi helps pharmaceutical operators manage critical equipment, GxP compliance, intervention traceability and production systems integration.
What we do for pharmaceuticals
Three areas of expertise, one goal: maintain GxP compliance, trace interventions and integrate your production systems.
Qualified maintenance & GxP assets
Production equipment, utilities and instruments in the pharmaceutical industry require qualified, documented and traceable maintenance. Sinorfi structures maintenance plans, qualified work orders and histories in IBM Maximo.
Regulatory compliance & traceability
FDA, EMA, ANSM, 21 CFR Part 11, ALCOA: the pharmaceutical sector imposes some of the strictest traceability requirements. Sinorfi helps document, audit and validate interventions in IBM Maximo in compliance with regulatory frameworks.
MES, ERP & quality systems integration
The pharmaceutical production chain relies on multiple systems: MES, ERP (SAP), quality systems, LIMS. Sinorfi connects IBM Maximo to these tools to ensure data consistency and automate maintenance-production-quality flows.
The challenges of the pharmaceutical sector
The pharmaceutical sector imposes some of the strictest traceability, validation and compliance requirements. Maintenance of production equipment, utilities and instruments must be documented, qualified and audited continuously according to FDA, EMA and ICH frameworks.
Sinorfi helps pharmaceutical operators structure their IBM Maximo assets, maintain GxP compliance, trace and qualify interventions, and connect their MES, ERP and quality systems.
Pharmaceutical use cases
Secure your pharmaceutical compliance
Let's discuss your qualified maintenance, GxP compliance and systems integration challenges in the pharmaceutical industry.
Frequently asked questions
Yes. Sinorfi adapts its IBM Maximo, EAM, GxP compliance, data and SI integration expertise to the sector's specific constraints.
Yes. A diagnostic or pilot helps frame the need, validate priority use cases and reduce risk before a wider deployment.